Skip to main content
. 2018 Jan 10;89(8):828–835. doi: 10.1136/jnnp-2017-316437

Table 2.

(Left) PDQ-39 scores (all dimensions and index score) at T0 and T1 for controls and experimental group, and (right) PDQ-39 delta values (T1–T0) for controls and experimental group

Controls Experimental group Controls Experimental group P
T0 T1 P T0 T1 P Delta T1–T0 Delta T1–T0
PDQ-39 index score 41.6±22.9 42.8±22.9 0.23 43.6±21.4 35.3±22.1 <0.0001 1.2±9.9 −8.3±18.0 <0.0001
Mobility 13.3±10.7 13.4±10.4 0.54 13.6±9.3 11.5±10.2 <0.0001 0.1±4.8 −2.0±7.6 0.0047
ADL 6.8±5.5 6.7±5.7 0.36 6.7±5.0 5.6±5.3 <0.0001 −0.1±2.9 −1.2±4.3 0.0160
Emotional well-being 6.5±5.0 7.1±4.7 0.10 7.0±4.6 5.6±4.7 <0.0001 0.6±2.8 −1.4±4.1 <0.0001
Stigma 4.6±1.9 5.0±2.4 0.80 4.5±2.7 4.4±2.4 0.8025 0.3±2.2 −0.1±2.7 0.71
Social support 2.0±1.9 2.1±2.0 0.60 2.0±2.2 1.3±2.0 <0.0001 0.1±1.6 −0.7±2.3 0.0093
Cognition 3.3±2.4 3.4±2.2 0.49 3.8±2.9 2.5±2.4 <0.0001 0.1±1.4 −1.2±2.5 <0.0001
Communication 2.1±2.4 2.0±2.1 0.56 2.2±2.2 1.4±1.7 <0.0001 −0.1±1.3 −0.8±2.0 0.0015
Bodily discomfort 3.1±2.6 3.2±2.5 0.65 3.7±2.7 2.9±2.5 <0.0001 0.1±1.5 −0.8±2.4 0.0016

ADL, activities of daily living; PDQ-39, Parkinson’s Disease Questionnaire-39.